IQVIA Holdings Inc

IQV

Company Profile

  • Business description

    Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

  • Contact

    2400 Ellis Road
    DurhamNC27703
    USA

    T: +1 919 998-2000

    E: [email protected]

    https://www.iqvia.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    93,000

Stocks News & Analysis

stocks

Wide moat stock exchange remains cheap

Aussie stock exchange remains materially undervalued despite growing cost concerns.
stocks

ASX data center player expands pipeline but questions remain

Questions surround Australia’s largest data center developer and its growing pipeline.
stocks

Cheap e-commerce share continues sales momentum

The e-commerce business continues its sales momentum despite challenging backdrop.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,965.0077.800.88%
CAC 408,183.345.53-0.07%
DAX 4025,104.7012.450.05%
Dow JONES (US)51,032.46363.490.72%
FTSE 10010,409.2816.68-0.16%
HKSE25,182.39176.230.70%
NASDAQ26,972.6255.150.20%
Nikkei 22566,329.501,636.382.53%
NZX 50 Index13,244.5538.440.29%
S&P 5007,580.0616.430.22%
S&P/ASX 2008,731.7073.100.84%
SSE Composite Index4,068.5730.07-0.73%

Market Movers